Board of Directors

Ben Chien - Chairman &CEO

Legal Representative of Foresee Pharmaceuticals, Inc.


Education:

Ph.D. in Analytical Chemistry, University of Michigan

Professional background:

DuPont Merck Pharmaceuticals, Inc.

Co-founder of Theracor Pharmaceuticals, Inc.

Chairman and CEO of QPS Holdings, LLC

Board Member of Delaware Bioscience Association

Consultant of Chinese Bioscience Association, Bay Area, San Francisco

Current position:

Chairman and CEO, Foresee Pharmaceuticals Co., Ltd.

Director of Foresee Pharmaceuticals USA, Inc.

Director of Foresee Pharmaceuticals Canada, Inc.

Chairman of Foresee Pharmaceuticals, Inc.

Member of Foresee Pharmaceuticals, LLC

Chairman of QPS Holding, LLC

Director of QPS Group Holdings, LLC

Member of QPS, LLC

Member of BKCA, LLC

Member of QPS MRA, LLC

Director of XDD Acquisition B.V.

Director of QPS Austria GmbH

Director of QPS Netherlands B.V.

Director of QPS Bioserve India Pvt. Ltd.

Chairman of QPS Taiwan

Chairman of Qualitix Clinical Research

Chairman of Unitix Clinical Research Co., Ltd.

Executive Director / President of Kuale Tisi (Shanghai) Medical Company Information Consultation Co., Ltd.

Executive Director of QPS Shanghai Co., Ltd.

 

Vincent Yen – Director

Legal Representative of Foresee Pharmaceuticals, Inc.


Education:

MBA, Fu Jen Catholic University

Professional background:

Unilever (China) Regional Manager

Gillette (Taiwan) Director

QPS Regional GM of Asia

Current position:

Member of QPS Holding, LLC

Member of QPS, LLC

Member of BKCA, LLC

Member of QPS MRA, LLC

Director of QPS Bioserve India Pvt. Ltd.

Director and President of QPS Taiwan

Director and President of Qualitix Clinical Research

Director of Unitix Clinical Research Co., Ltd.

President of QPS Shanghai Co., Ltd.

Yisheng Lee – Director

Legal Representative of Foresee Pharmaceuticals, Inc.

Education:

Ph.D. in Cancer Immunology / Pathology, Duke University

Professional background:

Assistant professor at Stanford University

Associate Clinical Professor at University of California, San Francisco

Current position:

Director and Chief Medical Officer, Foresee Pharmaceuticals Co., Ltd.

Director of Foresee Pharmaceuticals, Inc.

Director of ForeSee Pharmaceutical LLC

Director of QPS (Quest Pharmaceutical Service) Inc.

Member of QPS Holding, LLC

Director of QPS Group Holdings, LLC

Member of QPS, LLC

Member of BKCA, LLC

Member of QPS MRA, LLC

Director of QPS Taiwan

Member of BioQuiddity Incorporated, Medical Advisory Board

Attending physician of Pediatric Hematology/Oncology, Northern California Children’s Hematology & Oncology Program

George Jia-Long Lee – Director

Education:

Ph.D. in Chemistry, New York State University

Professional background:

R&D Manager of Syntex

Chairman of Epitomics

Current position:

Chairman of GenePharm Biotech Corp

Chairman of SunWay Biotech Co., Ltd.

Chairman of Applied Biocode Taiwan Ltd.

Chairman of BioKey Inc.

Chairman of Genepharm, Inc.

Chairman of RevMAb, Inc.

Chairman of Applied Biocode Inc.

Director of BlossomHill Therapeutics, Inc.

Jeff Wang – Director

Education:

Ph.D. in Chemistry, University of Pittsburgh

Professional background:

CEO of Development Center for Biotechnology

Senior Researcher and Lead Researcher of DuPont and Merck & Co., Inc.

Post-doctoral research at Harvard University

Current position:

Independent Director of UniPharma Co., Ltd.

Director and President of BioGate Precision Medicine Corp.

Independent Director of Luminescence Technology Corp.

Fu-Shiow Yin – Independent Director

Education:

Ph.D. in Philosophy, University of Rochester

Professional background:

Technical Consultant at the Department of Industrial Technology, Ministry of Economic Affairs

Investment Evaluation Committee Member of Boston Life Science Venture Corp.

Independent Director of Pac-Link Bio Venture Capital Investment Corp.

Representative of Institutional Director, TaiGen Biotechnology Co., Ltd.
Director of Reber Genetics Co., Ltd.
Independent Director of PharmaEngine, Inc.

Current position:

Independent Director of EirGenix, Inc.

 

Hank Lai – Independent Director

Education:

Master of Business Administration, National Taipei University

Professional background:

Staff member, commissioner, auditor, section chief, senior auditor, deputy head at Securities and Futures Bureau, Financial Supervisory Commission

Senior secretary at Financial Supervisory Commission, Executive Yuan

Vice President of Motor Vehicle Accident Compensation Fund

Independent Director of PharmaEngine, Inc.

Independent Supervisor of TSH Biopharm

Independent Director of Yuanta Futures Co., Ltd.

Current position:

Independent Director of Yuanta Securities Co., Ltd.

Independent Director of Excellence Optoelectronics Inc.


Frank Wen-Chi Lee – Independent Director

Education:

Ph.D. in Medical Chemistry, University of California, San Francisco

Professional background:

Millennium Pharmaceuticals, Inc. (The Takeda Oncology Company)

Director of New Pharmacokinetic Drug Research, Senior Director, Manager at Pharmacokinetics Division, Vice President of the Non-Clinical Development Department

Director of New Pharmacokinetic Drug Research, DuPont Pharmaceuticals Company

Research project manager, Glaxo Wellcome Inc.

Senior Research Researcher and Primary Scientific Researcher, Glaxo Inc.

Senior chemist of pharmacokinetics, Syntex Research Institute

Current position:

Director and Chief Strategy Officer of BRIM Biotechnology, Inc.

FWL Consulting Services, LLC Principle

Co-founder of Chinese Entrepreneur Association (non-profit organization)